Targeted treatments and immunotherapy for Upper GI Cancers
Virtual delivery via MS TeamsThis course provides an overview of the targeted therapies and immunotherapies given to some people with oesophageal, stomach, pancreatic or liver cancer, or cancers of the biliary system
The 4Ps Researcher Development Programme (January – May 2026) Cohort 10
Virtual delivery via MS TeamsThe 4Ps Programme has been developed by research active healthcare professionals in Newcastle and is designed to support colleagues' needs no matter where they are on the “research interested” to “Aspiring Clinical Academic” continuum
Targeted treatments and immunotherapy for Bowel Cancer
Virtual delivery via MS TeamsThis course describes how bowel cancer comes about, and explains the reasons why some patients might be given treatments such as EGFR-targeted antibodies (cetuximab and panitumumab), angiogenesis inhibitors (bevacizumab and regorafenib), or immune checkpoint inhibitors (pembrolizumab) as part of their treatment.
Introduction to the Science of Systemic Cancer Treatments and Cancer Biomarkers
Virtual delivery via MS TeamsKnowledge gained through this course will enhance learners’ understanding of cancer biology, the mechanism of action of systemic cancer treatments, and the use of biomarkers to select the best treatments for each patient and as a result empower staff to feel confident when communicating with patients and their families, and with clinical and non-clinical colleagues.
The 4Ps Researcher Development Programme (September – December 2025) Cohort 9
Virtual delivery via MS TeamsThe 4Ps Programme has been developed by research active Nurses, Midwives and Allied Health Professionals in Newcastle and is designed to support your needs no matter where you are on the “research interested” to “Aspiring Clinical Academic” continuum
Radiation Protection Supervisor (RPS) Training
Virtual delivery via MS TeamsOur Radiation Protection Supervisors Training encompasses the fundamental principles of radiation safety combined with practical scenario based teaching with the aim to provide you with the appropriate knowledge and confidence to fulfil your duties as an RPS in your workplace.
The 4Ps Researcher Development Programme (April – September 2025) Cohort 8
Virtual delivery via MS TeamsThe 4Ps Programme has been developed by research active Nurses, Midwives and Allied Health Professionals in Newcastle and is designed to support your needs no matter where you are on the “research interested” to “Aspiring Clinical Academic” continuum
Targeted Treatments and Immunotherapy for Solid Tumours: Demystifying the Science – February 2025
Virtual delivery via MS TeamsThis course gives cancer nurses and trial staff the knowledge and confidence to discuss a wide range of targeted cancer treatments and immunotherapies with patients and colleagues.
Targeted treatments and immunotherapies for breast cancer – January 2025
Virtual delivery via MS TeamsIdeal for research nurses, clinical nurse specialists, pharmacists, clinical trials and other staff who already have some knowledge of the different types of breast cancers. Delivered over two morning sessions, Dr Elaine Vickers – a leading independent educator on the science of new cancer treatments – will guide you through many of the most relevant topics relating to modern systemic treatments for breast cancer.
The 4Ps Researcher Development Programme (January – May 2025) Cohort 7
Virtual delivery via MS TeamsThe 4Ps Programme has been developed by Newcastle's Nurses, Midwives and Allied Health Professionals and designed to support your needs no matter where you are on the “research interested” to “Aspiring Clinical Academic” continuum.
Targeted treatments and immunotherapy for non-small cell lung cancer – December 2024
Virtual delivery via MS TeamsIdeal for research nurses, clinical nurse specialists, pharmacists, clinical trials coordinators and any other healthcare professionals involved in the diagnosis and treatment of people with lung cancer. Delivered over two morning sessions, Dr Elaine Vickers – leading independent educator on the science of new cancer treatments – will guide delegates through many of the most relevant topics relating to modern systemic treatments for non-small cell lung cancer (NSCLC).
Novel Immunotherapies for Solid Tumours – November 2024
Virtual delivery via MS TeamsThis 3-hour virtual course emphasises the progress made in developing novel immunotherapies for solid tumours, such as CAR T cell therapy, TCR-engineered T cell therapy, tumour infiltrating lymphocytes, T cell engagers, and vaccine-based treatments.